Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSThree Regulatory News (STEM)

Share Price Information for SThree (STEM)

Share Price is delayed by 15 minutes
Get Live Data
168.40    -2.00 (-1.17%)
Bid:
167.80
Ask:
168.60
Spread: 0.80 (0.477%)
Market Cap: £206.65m
STEM Live PriceLast checked at - London Stock Exchange

Intraday SThree Share Chart

Q3 Trading Update

15 Sep 2017 07:02

SThree (STHR) Q3 Trading Update 15-Sep-2017 / 07:00 GMT/BST Dissemination of a Regulatory Announcement that contains inside information according to REGULATION (EU) No 596/2014 (MAR), transmitted by EQS Group. The issuer is solely responsible for the content of this announcement.


15 September 2017

 

 

Q3 Trading Update

 

 

SThree plc ("SThree" or the "Group"), the international specialist STEM staffing business, is today issuing a trading update covering the period from 1 June 2017 to date; financial information relates to the quarter ended 31 August 2017.

 

Highlights

 

Group gross profit ("GP") up 5%* YoY in Q3, with sustained momentum from Q2 when Group GP grew by 4%* Solid growth across Engineering up 5%* YoY, Life Sciences up 3%* and Global Energy up 35%* Strong growth in USA up 20%* YoY Robust performance in Continental Europe up 6% YoY UK&I remains challenging down 10%* YoY, in line with management expectations Contract GP up 9%* YoY, with strong growth across Engineering up 10%*, Life Sciences up 13%* and Energy up 37%* Permanent GP down 6%* YoY, broadly in line with average sales headcount down 7% 80% of Group GP generated outside the UK&I (2016: 76%) Group period-end sales headcount up 3% on the 2016 year-end position, and up 4% YoY Full year 2017 adjusted profit before tax expected to be ahead of current consensus+

 

+ Consensus for the year ended 30 November 2017 is £42.4m, with a range of £39.3m to £45.6m

 

 

Gary Elden, Chief Executive, commented: "We are pleased with our sustained momentum in the period, with gross profit showing a sequential increase over Q2. A robust performance in Continental Europe and further strong growth in the USA were particular highlights and our Contract business is continuing to drive growth across the Group.

 

"We are well-positioned for the final quarter and now expect to deliver a full year result ahead of current consensus."

 

 

Financial Highlights -

 

 

 

 

Group Gross Profit

 

 

 

 

 

 

 

Q3 2017

Q2 2017

Q1 2017

Gross Profit

Q3 2017

Q3 2016

YoY % 1

YoY % 1

YoY % 1

 

 

 

 

 

 

Contract

£53.1m

£45.4m

+9%

+9%

+7%

Permanent

£20.6m

£20.6m

-6%

-6%

-14%

Group

£73.7m

£66.0m

+5%

+4%

-

 

 

 

 

 

 

UK&I

£14.5m

£15.8m

-10%

-14%

-19%

Continental Europe

£37.9m

£32.9m

+6%

+7%

+7%

USA

£17.3m

£13.5m

+20%

+20%

+12%

Asia Pac & Middle East

£4.0m

£3.8m

+1%

+5%

-14%

Group

£73.7m

£66.0m

+5%

+4%

-

 

 

 

 

 

 

ICT

£31.6m

£29.3m

+1%

+1%

+2%

Banking & Finance

£11.3m

£10.5m

+1%

-1%

-8%

Energy

£7.1m

£4.8m

+35%

+23%

-8%

Engineering

£6.9m

£6.2m

+5%

+3%

-1%

Life Sciences

£15.6m

£14.3m

+3%

+7%

+4%

Other Sectors 3

£1.2m

£0.9m

+24%

+13%

+4%

Group

£73.7m

£66.0m

+5%

+4%

-

 

 

 

 

 

 

Contract / Perm Split

 

 

 

 

 

Contract

72%

69%

 

 

 

Permanent

28%

31%

 

 

 

 

100%

100%

 

 

 

 

 

 

 

 

 

Geographical Split

 

 

 

 

 

UK&I

20%

24%

 

 

 

Continental Europe

52%

50%

 

 

 

USA

23%

20%

 

 

 

Asia Pac & Middle East

5%

6%

 

 

 

 

100%

100%

 

 

 

 

 

 

 

 

 

Sector Split

 

 

 

 

 

ICT

43%

44%

 

 

 

Banking & Finance

15%

16%

 

 

 

Energy

10%

7%

 

 

 

Engineering

9%

10%

 

 

 

Life Science

21%

22%

 

 

 

Other Sectors 3

2%

1%

 

 

 

 

100%

100%

 

 

 

 

 

 

 

 

 

 

 

 

Q3 2017

Q2 2017

Q1 2017

Operating Metrics

Q3 2017

Q3 2016

YoY %

YoY %

YoY %

 

 

 

 

 

 

Contract Runners 2

 

 

 

 

 

UK&I

2,512

2,693

-7%

-6%

-8%

Continental Europe

4,925

4,174

+18%

+19%

+19%

USA

1,631

1,316

+24%

+23%

+14%

Asia Pac & Middle East

489

411

+19%

+25%

+19%

Group

9,557

8,594

+11%

+12%

+9%

 

 

 

 

 

 

 

 

 

 

 

 

1 At constant currency

 

 

 

 

2 Period-end number of contractors onsite with clients

3 Other Sectors includes Procurement & Supply Chain and Sales & Marketing

 

Group gross profit ("GP") was up 5%* YoY and up 5%* sequentially vs Q2, with Q2 having been up 4%* YoY after a flat performance in Q1. USA GP was ahead by 20%* YoY in the quarter, another strong performance after being up 20%* in Q2. Continental Europe posted a robust performance in the quarter up 6%* YoY. Sales headcount for the Group was up 4% YoY and 3% ahead of the 2016 year end position.

 

Contract continues to perform strongly, up 9%* YoY with a large proportion of the growth in the quarter from Continental Europe up 12%* and USA up 24%*, offset by a decline in the UK&I, down 10%*. On a sector basis, the Group maintained strong growth in Engineering up 10%* YoY and Life Sciences up 13%*. We continued to prioritise growth in Contract sales headcount, with an average increase in the quarter of 8% YoY.

 

Permanent GP was down 6%* YoY, broadly in line with average sales headcount down 7% YoY. In the quarter, Permanent GP in UK&I declined by 12%* YoY, Continental Europe declined by 9%*, offset by a strong performance in USA, up 12%*.

 

Average Group sales heads were up 2% YoY. UK&I sales headcount was down 9% YoY, Continental Europe was up 13%, USA was down 3% and Asia Pacific & Middle East was down 15%. Contract sales headcount represented 65% of total sales headcount at the end of the quarter (2016: 62%).

 

The Group has a network of 39 offices in 16 countries, of which 32 are outside the UK. The Group generated 80% of Gross Profit for the period from markets outside the UK&I (2016: 76%).

 

SThree remains in a strong financial position. Net debt at 31 August 2017 was circa £8m (31 August 2016: £14m). The Group has a £50m revolving credit facility ("RCF") with Citibank and HSBC, which is committed to 2019.

 

 * at constant currency

 

SThree is hosting an analyst conference call today at 0830 BST. The details are as follows:

 

Telephone number: +44 (0) 20 3003 2666

 

For access to the call please quote passcode SThree

 

A replay facility will be available for seven days on +44 (0) 20 8196 1998 followed by 1582104#         

 

The Group will be hosting a Capital Markets Day in London on the afternoon of 15 November 2017.

 

The Group will issue a trading update for the year ended 30 November 2017 on 15 December 2017.

 

- Ends -

 

 

Enquiries:

 

 SThree plc

020 7268 6000

 Gary Elden, Chief Executive Officer

 

 Alex Smith, Chief Financial Officer

 

 Sarah Anderson, Deputy Company Secretary/IR Enquiries

 

 

 Citigate Dewe Rogerson

020 7638 9571

 Kevin Smith/Jos Bieneman

 

 

 

Notes to editors

 

SThree is a leading international specialist staffing business, providing permanent and contract specialist staff to a diverse client base of over 7,000 clients. From its well-established position as a major player in the information and communications technology ('ICT') sector the Group has broadened the base of its operations to include businesses serving the Banking & Finance, Energy, Engineering and Life Sciences sectors.

 

Since launching its original business, Computer Futures, in 1986, the Group has adopted a multi-brand strategy, establishing new operations to address growth opportunities. SThree brands include Computer Futures, Huxley Associates, Progressive and The Real Staffing Group. The Group has circa 2,700 employees in sixteen countries.

 

SThree plc is quoted on the Official List of the UK Listing Authority under the ticker symbol STHR and also has a US level one ADR facility, symbol SERTY.

 

 

Important notice

 

Certain statements in this announcement are forward looking statements. By their nature, forward looking statements involve a number of risks, uncertainties or assumptions that could cause actual results or events to differ materially from those expressed or implied by those statements. Forward looking statements regarding past trends or activities should not be taken as representation that such trends or activities will continue in the future. Certain data from the announcement is sourced from unaudited internal management information and is before any exceptional items. Accordingly, undue reliance should not be placed on forward looking statements. 

 


ISIN:GB00B0KM9T71
Category Code:TST
TIDM:STHR
LEI Code:2138003NEBX5VRP3EX50
Sequence No.:4635
 
End of AnnouncementEQS News Service

609909 15-Sep-2017 

UK-Regulatory-announcement transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement.

Date   Source Headline
4th Feb 20257:00 amRNSTransaction in Own Shares
3rd Feb 20259:59 amRNSTotal Voting Rights
3rd Feb 20257:00 amRNSTransaction in Own Shares
31st Jan 20257:00 amRNSTransaction in Own Shares
30th Jan 20257:00 amRNSTransaction in Own Shares
29th Jan 20257:00 amRNSTransaction in Own Shares
28th Jan 20257:00 amRNSFY24 Final Results
28th Jan 20257:00 amRNSTransaction in Own Shares
27th Jan 20257:00 amRNSTransaction in Own Shares
24th Jan 202510:10 amRNSDirectorate Change
24th Jan 20257:00 amRNSTransaction in Own Shares
23rd Jan 20257:00 amRNSTransaction in Own Shares
22nd Jan 20257:00 amRNSTransaction in Own Shares
21st Jan 20257:00 amRNSTransaction in Own Shares
20th Jan 20257:00 amRNSTransaction in Own Shares
17th Jan 20257:00 amRNSTransaction in Own Shares
16th Jan 20257:00 amRNSTransaction in Own Shares
15th Jan 20257:00 amRNSTransaction in Own Shares
14th Jan 20257:00 amRNSTransaction in Own Shares
13th Jan 20253:28 pmRNSDirector/PDMR Shareholding
13th Jan 20257:00 amRNSTransaction in Own Shares
10th Jan 20257:00 amRNSTransaction in Own Shares
9th Jan 20257:00 amRNSTransaction in Own Shares
8th Jan 20257:00 amRNSTransaction in Own Shares
7th Jan 20257:00 amRNSTransaction in Own Shares
6th Jan 20257:00 amRNSTransaction in Own Shares
3rd Jan 20257:00 amRNSTransaction in Own Shares
2nd Jan 20254:05 pmRNSTotal Voting Rights
2nd Jan 20257:00 amRNSTransaction in Own Shares
31st Dec 20247:00 amRNSTransaction in Own Shares
30th Dec 20247:00 amRNSTransaction in Own Shares
27th Dec 20247:00 amRNSTransaction in Own Shares
24th Dec 20247:00 amRNSTransaction in Own Shares
23rd Dec 20247:00 amRNSTransaction in Own Shares
20th Dec 20247:00 amRNSTransaction in Own Shares
19th Dec 20247:00 amRNSCommencement of Share Buyback
17th Dec 20249:11 amRNSDirector/PDMR Shareholding
12th Dec 20244:49 pmRNSDirector/PDMR Shareholding
12th Dec 20247:00 amRNSTrading Update
10th Dec 20241:15 pmRNSDirector/PDMR Shareholding
19th Nov 20243:01 pmRNSHolding(s) in Company
14th Nov 202412:30 pmRNSDirector/PDMR Shareholding
13th Nov 202410:05 amRNSDirector/PDMR Shareholding
1st Nov 20249:28 amRNSTotal Voting Rights
14th Oct 20245:19 pmRNSDirector/PDMR Shareholding
1st Oct 202410:10 amRNSTotal Voting Rights
25th Sep 20243:07 pmRNSDirector/PDMR Shareholding
24th Sep 20247:00 amRNSFY24 Q3 Trading Update
16th Sep 20243:00 pmRNSDirector/PDMR Shareholding
3rd Sep 20244:42 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.